Literature DB >> 24355484

Exposure of fallopian tube epithelium to follicular fluid mimics carcinogenic changes in precursor lesions of serous papillary carcinoma.

K Bahar-Shany1, H Brand2, S Sapoznik1, J Jacob-Hirsch1, Y Yung3, J Korach4, T Perri4, Y Cohen5, A Hourvitz6, K Levanon7.   

Abstract

OBJECTIVES: Ovulation-related inflammation is suspected to have a causal role in ovarian carcinogenesis, but there are no human models to study the molecular pathways. Our aim is to develop such an ex-vivo model based on human fallopian tube (FT) epithelium exposed to human follicular fluid (FF).
METHODS: FT epithelium was dissociated from normal surgical specimens. FF was obtained from donors undergoing in-vitro fertilization. The cells were cultured on collagen-coated Transwells and incubated with FF for various periods of time. The transcriptomic changes resulting from FF treatment were profiled using Affymetrix expression arrays. Specific characteristics of the FT pre-cancerous lesions were studied using immunohistochemistry, immunofluorescence, RT-PCR and XTT assay.
RESULTS: We show that FF exposure causes up-regulation of inflammatory and DNA repair pathways. Double stranded DNA breaks are induced. There is a minor increase in cell proliferation. TP53, which is the hallmark of the precursor lesion in-vivo, is accumulated. Levels of expression and secretion of Interleukin-8 are significantly increased.
CONCLUSIONS: Our model addresses the main non-genetic risk factor for ovarian cancer, namely the impact of ovulation. This study demonstrates the biological implications of in-vitro exposure of human FT epithelial cells to FF. The model replicates elements characterizing the precursor lesions of ovarian cancer, and warrants further investigation of the linkage between repeated exposure to ovulation-related damage and accumulation of neoplastic changes.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biomarkers; Carcinogenesis; Fallopian tube; Follicular fluid; Ovarian cancer; Ovulation

Mesh:

Year:  2013        PMID: 24355484     DOI: 10.1016/j.ygyno.2013.12.015

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  39 in total

Review 1.  Epithelial ovarian cancer - more data, more questions?

Authors:  Stefanie Aust; Dietmar Pils
Journal:  Wien Med Wochenschr       Date:  2014-11-13

Review 2.  It's Totally Tubular....Riding The New Wave of Ovarian Cancer Research.

Authors:  Ruth Perets; Ronny Drapkin
Journal:  Cancer Res       Date:  2015-12-15       Impact factor: 12.701

3.  Cytidine deaminase Apobec3a induction in fallopian epithelium after exposure to follicular fluid.

Authors:  Pavla Brachova; Nehemiah S Alvarez; Bradley J Van Voorhis; Lane K Christenson
Journal:  Gynecol Oncol       Date:  2017-02-16       Impact factor: 5.482

Review 4.  Preclinical Models of Ovarian Cancer: Pathogenesis, Problems, and Implications for Prevention.

Authors:  Anthony N Karnezis; Kathleen R Cho
Journal:  Clin Obstet Gynecol       Date:  2017-12       Impact factor: 2.190

5.  Microvesicle Proteomic Profiling of Uterine Liquid Biopsy for Ovarian Cancer Early Detection.

Authors:  Georgina D Barnabas; Keren Bahar-Shany; Stav Sapoznik; Limor Helpman; Yfat Kadan; Mario Beiner; Omer Weitzner; Nissim Arbib; Jacob Korach; Tamar Perri; Guy Katz; Anna Blecher; Benny Brandt; Eitan Friedman; David Stockheim; Ariella Jakobson-Setton; Ram Eitan; Shunit Armon; Hadar Brand; Oranit Zadok; Sarit Aviel-Ronen; Michal Harel; Tamar Geiger; Keren Levanon
Journal:  Mol Cell Proteomics       Date:  2019-02-13       Impact factor: 5.911

Review 6.  Rationale for Developing a Specimen Bank to Study the Pathogenesis of High-Grade Serous Carcinoma: A Review of the Evidence.

Authors:  Mark E Sherman; Ronny I Drapkin; Neil S Horowitz; Christopher P Crum; Sue Friedman; Janice S Kwon; Douglas A Levine; Ie-Ming Shih; Donna Shoupe; Elizabeth M Swisher; Joan Walker; Britton Trabert; Mark H Greene; Goli Samimi; Sarah M Temkin; Lori M Minasian
Journal:  Cancer Prev Res (Phila)       Date:  2016-05-24

Review 7.  Iron overload and altered iron metabolism in ovarian cancer.

Authors:  Stephanie Rockfield; Joseph Raffel; Radhe Mehta; Nabila Rehman; Meera Nanjundan
Journal:  Biol Chem       Date:  2017-08-28       Impact factor: 3.915

8.  Invited Commentary: Relationship Between Ovulation and Markers of Systemic Inflammation Versus Markers of Localized Inflammation.

Authors:  Joellen M Schildkraut
Journal:  Am J Epidemiol       Date:  2020-07-01       Impact factor: 4.897

Review 9.  The disparate origins of ovarian cancers: pathogenesis and prevention strategies.

Authors:  Anthony N Karnezis; Kathleen R Cho; C Blake Gilks; Celeste Leigh Pearce; David G Huntsman
Journal:  Nat Rev Cancer       Date:  2016-11-25       Impact factor: 60.716

Review 10.  Fallopian tube initiation of high grade serous ovarian cancer and ovarian metastasis: Mechanisms and therapeutic implications.

Authors:  Tova M Bergsten; Joanna E Burdette; Matthew Dean
Journal:  Cancer Lett       Date:  2020-02-15       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.